Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Timothy A. Horwedel & Daniel C. Brennan. (2016) Extended-release tacrolimus tablets for preventing organ transplant rejection. Expert Opinion on Orphan Drugs 4:10, pages 1079-1086.
Read now
Read now
Jane Revollo. (2015) Update on the clinical utility of once-daily tacrolimus in the management of transplantation. Drug Design, Development and Therapy 9, pages 2581-2584.
Read now
Read now
Articles from other publishers (29)
Itxarone Bilbao, Miguel Ángel Gómez Bravo, Alejandra Otero, Laura Lladó, José Luís Montero, Luisa González Dieguez, Javier Graus & José Antonio Pons Miñano. (2023) Effectiveness and safety of once‐daily tacrolimus formulations in de novo liver transplant recipients: The PRETHI study. Clinical Transplantation.
Crossref
Crossref
D. S. Wöhl, B. James, M. Götz, F. Brennfleck, I. Holub-Hayles, I. Mutzbauer, S. Baccar, S. M. Brunner, E. K. Geissler, H. J. Schlitt, Florian W. R. Vondran, Uta Herden, Jens Mittler, Ulf Peter Neumann, Silvio Nadalin, Andreas A. Schnitzbauer, Falk Rauchfuß, Felix Braun, Katharina Willuweit, Johann Pratschke, Thomas Berg, Thomas Vogel, Uta Merle & Roland Croner. (2023) EnGraft: a multicentre, open-label, randomised, two-arm, superiority study protocol to assess bioavailability and practicability of Envarsus® versus Advagraf™ in liver transplant recipients. Trials 24:1.
Crossref
Crossref
Thomas Soliman, Georg Gyoeri, Andreas Salat, Vladimír Mejzlík & Gabriela Berlakovich. (2023) A Multi-Centre Non-Interventional Study to Assess the Tolerability and Effectiveness of Extended-Release Tacrolimus (LCPT) in De Novo Liver Transplant Patients. Journal of Clinical Medicine 12:7, pages 2537.
Crossref
Crossref
Ester Cholbi Vives, Jordi Espí Reig, Andrés Cruz Sánchez, Elena Moreno Maestre, Ana Ventura Galiano, David Ramos Escorihuela, María Ramos Cebrián, Pablo González-Calero Borrás, Isabel Beneyto Castelló & Julio Hernández Jaras. (2022) Comparative Study of 2 Extended-Release Tacrolimus Formulations in Kidney Transplantation. Transplantation Proceedings 54:9, pages 2434-2438.
Crossref
Crossref
Georgia Tsakiridou, Patrick J. O'Dwyer, Antonios Margaritis, Karl J. Box, Maria Vertzoni, Lida Kalantzi & Christos Reppas. (2022) On the usefulness of four in vitro methodologies in screening for product related differences in tacrolimus exposure after oral administration of amorphous solid dispersions with modified release characteristics in the fasted state. Journal of Drug Delivery Science and Technology 69, pages 102990.
Crossref
Crossref
Uta Herden, Martina Sterneck, Bettina M. Buchholz, Eike G. Achilles, Armin Ott & Lutz Fischer. (2021) A single‐center, open‐label, randomized cross‐over study to evaluate the pharmacokinetics and bioavailability of once‐daily prolonged‐release formulations of tacrolimus in de novo liver transplant recipients. Immunity, Inflammation and Disease 9:4, pages 1771-1780.
Crossref
Crossref
Arnaud Del Bello, Clotilde Gaible, Nathalie Longlune, Anne-Laure Hebral, Laure Esposito, Peggy Gandia & Nassim Kamar. (2021) Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation. Frontiers in Pharmacology 12.
Crossref
Crossref
Emilie Henin, Mirco Govoni, Massimo Cella, Christian Laveille & Giovanni Piotti. (2021) Therapeutic Drug Monitoring Strategies for Envarsus in De Novo Kidney Transplant Patients Using Population Modelling and Simulations. Advances in Therapy 38:10, pages 5317-5332.
Crossref
Crossref
Katharina Willuweit, Alexandra Frey, Anne Hörster, Fuat Saner & Kerstin Herzer. (2020) Real-World Administration of Once-Daily MeltDose® Prolonged-Release Tacrolimus (LCPT) Allows for Dose Reduction of Tacrolimus and Stabilizes Graft Function Following Liver Transplantation. Journal of Clinical Medicine 10:1, pages 124.
Crossref
Crossref
E.L. Parodi, E. La Porta, R. Russo, L. Marsano, D. Bellino, E. Paoletti, F. Massarino, A. Sofia, G. Garibotto, P. Esposito, A. Murugavel, F. Cappadona, I. Fontana, F. Viazzi & D. Picciotto. (2020) Ten-Year Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant: A Prospective Cohort Study. Transplantation Proceedings 52:10, pages 3112-3117.
Crossref
Crossref
Nicholas W. Lange, Jessica Hedvat, Demetra S. Tsapepas & David M. Salerno. (2020) Managing the significant interaction between XR tacrolimus and fluconazole in kidney transplant recipients. Clinical Transplantation 34:8.
Crossref
Crossref
Aureliusz Kolonko, Małgorzata Jurys, Sebastian Sirek, Tomasz Dwulit, Dorota Pojda-Wilczek & Andrzej Więcek. (2020) The effect of Maintenance Treatment with Twice-daily or Prolonged Once-daily Tacrolimus Formulation on Visual Evoked Potentials in Stable Kidney Transplant Recipients. Journal of Clinical Medicine 9:6, pages 1827.
Crossref
Crossref
Johannes von Einsiedel, Gerold Thölking, Christian Wilms, Elena Vorona, Arne Bokemeyer, Hartmut H. Schmidt, Iyad Kabar & Anna Hüsing-Kabar. (2020) Conversion from Standard-Release Tacrolimus to MeltDose® Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation. Journal of Clinical Medicine 9:6, pages 1654.
Crossref
Crossref
Rainer Oberbauer, Oriol Bestard, Lucrezia Furian, Umberto Maggiore, Julio Pascual, Lionel Rostaing & Klemens Budde. (2020) Optimization of tacrolimus in kidney transplantation: New pharmacokinetic perspectives. Transplantation Reviews 34:2, pages 100531.
Crossref
Crossref
Ana Sánchez Fructuoso, Juan Carlos Ruiz, Antonio Franco, Fritz Diekmann, Dolores Redondo, Jesús Calviño, Nuria Serra, María José Aladrén, Secundino Cigarrán, Ana Manonelles, Ana Ramos, Gonzalo Gómez, José Manuel González Posada, Amado Andrés, Isabel Beneyto, Andrés López Muñiz, Manel Perelló & Ricardo Lauzurica. (2019)
Effectiveness and safety of the conversion to MeltDose
®
extended‐release tacrolimus from other formulations of tacrolimus in stable kidney transplant patients: A retrospective study
. Clinical Transplantation 34:1.
Crossref
Crossref
Somratai Vadcharavivad, Warangkana Saengram, Annop Phupradit, Nalinee Poolsup & Wiwat Chancharoenthana. (2019) Once-Daily versus Twice-Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies. Drugs 79:18, pages 1947-1962.
Crossref
Crossref
Umberto Baccarani, Jaqueline Velkoski, Riccardo Pravisani, Gian Luigi Adani, Dario Lorenzin, Vittorio Cherchi, Bruno Falzone, Massimo Baraldo & Andrea Risaliti. (2019) MeltDose Technology vs Once-Daily Prolonged Release Tacrolimus in De Novo Liver Transplant Recipients. Transplantation Proceedings 51:9, pages 2971-2973.
Crossref
Crossref
Jordan R Covvey & Erin E Mancl. (2019) Pharmaceutical care in transplantation: current challenges and future opportunities. Nanomedicine 14:20, pages 2651-2658.
Crossref
Crossref
Hui Xu, Li Liu, Xuehui Li, Junyuan Ma, Rui Liu & Shaoning Wang. (2019) Extended tacrolimus release via the combination of lipid-based solid dispersion and HPMC hydrogel matrix tablets. Asian Journal of Pharmaceutical Sciences 14:4, pages 445-454.
Crossref
Crossref
Nassim Kamar, Elisabeth Cassuto, Giovanni Piotti, Mirco Govoni, Giorgia Ciurlia, Silvia Geraci, Gianluigi Poli, Gabriele Nicolini, Christophe Mariat, Marie Essig, Paolo Malvezzi, Yannick Le Meur, Valerie Garrigue, Arnaud Del Bello & Lionel Rostaing. (2018) Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study. Advances in Therapy 36:2, pages 462-477.
Crossref
Crossref
Maja Nowicka, Monika Górska, Zuzanna Nowicka, Krzysztof Edyko, Piotr Edyko, Sebastian Wiślicki, Anna Zawiasa-Bryszewska, Janusz Strzelczyk, Józef Matych & Ilona Kurnatowska. (2019) Tacrolimus: Influence of the Posttransplant Concentration/Dose Ratio on Kidney Graft Function in a Two-Year Follow-Up. Kidney and Blood Pressure Research 44:5, pages 1075-1088.
Crossref
Crossref
Warangkana Saengram, Somratai Vadcharavivad, Nalinee Poolsup & Wiwat Chancharoenthana. (2018) Extended release versus immediate release tacrolimus in kidney transplant recipients: a systematic review and meta-analysis. European Journal of Clinical Pharmacology 74:10, pages 1249-1260.
Crossref
Crossref
Poovizhi Ponnammal, Parijat Kanaujia, Yin Yani, Wai Ng & Reginald Tan. (2018) Orally Disintegrating Tablets Containing Melt Extruded Amorphous Solid Dispersion of Tacrolimus for Dissolution Enhancement. Pharmaceutics 10:1, pages 35.
Crossref
Crossref
Kunal Patel, Carl Atkinson, Danh Tran & Satish N. Nadig. (2017) Nanotechnological Approaches to Immunosuppression and Tolerance Induction. Current Transplantation Reports 4:2, pages 159-168.
Crossref
Crossref
Giovanni Piotti, Elena Cremaschi & Umberto Maggiore. (2016) Once-daily prolonged-release tacrolimus formulations for kidney transplantation: what the nephrologist needs to know. Journal of Nephrology 30:1, pages 53-61.
Crossref
Crossref
A. Mercuri, S. Wu, S. Stranzinger, S. Mohr, S. Salar-Behzadi, M. Bresciani & E. Fröhlich. (2016) In vitro and in silico characterisation of Tacrolimus released under biorelevant conditions. International Journal of Pharmaceutics 515:1-2, pages 271-280.
Crossref
Crossref
Jamal Bamoulid, Oliver Staeck, Fabian Halleck, Dmytri Khadzhynov, Alexander Paliege, Susanne Brakemeier, Michael Dürr & Klemens Budde. (2016) Immunosuppression and Results in Renal Transplantation. European Urology Supplements 15:9, pages 415-429.
Crossref
Crossref
M. Baraldo. (2016) Meltdose Tacrolimus Pharmacokinetics. Transplantation Proceedings 48:2, pages 420-423.
Crossref
Crossref
Christine E. Staatz & Susan E. Tett. (2015) Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients. Clinical Pharmacokinetics 54:10, pages 993-1025.
Crossref
Crossref